Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125190251	12519025	1	I	20160420	20160628	20160701	20160701	EXP		US-ABBVIE-16P-163-1664957-00	ABBVIE		0.00			M	Y	95.00000	KG	20160630		PH	COUNTRY NOT SPECIFIED	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125190251	12519025	1	PS	VIEKIRA PAK	DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR	1	Oral				U		UNKNOWN		206619			TABLET	BID
125190251	12519025	2	SS	RIBASPHERE	RIBAVIRIN	1	Oral				U		UNKNOWN		0	600	MG	TABLET	BID

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125190251	12519025	1	Hepatitis C
125190251	12519025	2	Hepatitis C

Outcome of event

Event ID	CASEID	OUTC COD
125190251	12519025	OT

Reactions reported

Event ID	CASEID	PT
125190251	12519025	Chest pain
125190251	12519025	Dizziness
125190251	12519025	Dyspnoea
125190251	12519025	Epistaxis
125190251	12519025	Fall

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
125190251	12519025	1	20160402		0
125190251	12519025	2	20160402		0